Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Valencia
Clinical trial register · Spain

Clinical Trials in Valencia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 80 Madrid 65 Seville 37 Valencia 34 Málaga 18
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Valencia61 AstraZeneca60 Novartis Pharmaceuticals42 Hoffmann-La Roche41 AbbVie39 Clear sponsor filter
Site location
Barcelona80 Madrid65 Seville37 Valencia34 Málaga18
All 78 locations
Target enrolment
to

Trials with a site in Valencia

34 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Eli Lilly and Company
Phase 3
252
A Coruña, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Seville, Valencia
2026-06-01
Recruiting
Eli Lilly and Company
Phase 1
32
L'Hospitalet de Llobregat, Valencia
2026-05-14
Recruiting
Eli Lilly and Company
Phase 1
32
L'Hospitalet de Llobregat, Valencia
2026-05-14
Recruiting
Eli Lilly and Company
Phase 3
300
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Santander, Seville, Valencia
2026-02-05
Recruiting
Eli Lilly and Company
Phase 1
32
L'Hospitalet de Llobregat, Valencia
2025-08-05
Recruiting
Eli Lilly and Company
Phase 3
290
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Active, closed
Eli Lilly and Company
Phase 2
45
Barcelona, Córdoba, Esplugues de Llobregat, Madrid, Seville, Valencia
2024-10-25
Recruiting
Eli Lilly and Company
Phase 3
300
Barcelona, Córdoba, Madrid, Málaga, Valencia
2024-06-03
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
NCT06400472Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung
DrugsSofe-M·Itraconazole·Bevacizumab·Carboplatin
Eli Lilly and Company
Phase 1
575
Barcelona, Madrid, Valencia
2024-05-20
Recruiting
Eli Lilly and Company
Phase 3
90
Córdoba, Sabadell, Valencia
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
595
Badalona, Barcelona, Bilbao (Bizkaia), Madrid, Valencia
2023-02-27
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
DrugDonanemab
Eli Lilly and Company
Phase 3
1,500
Barcelona, Lleida, Sant Cugat del Vallès, Valencia
2022-10-10
Active, closed
Eli Lilly and Company
Phase 2
46
Barcelona, Esplugues de Llobregat, Madrid, Seville, Valencia
2022-09-20
Recruiting
Eli Lilly and Company
Phase 1
260
Barcelona, Madrid, Pozuelo de Alarcón, Valencia
2022-05-11
Active, closed
Eli Lilly and Company
Phase 3
925
Hospitalet, Madrid, Valencia, Badajoz, Seville
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
368
A Coruña, Palma, Barcelona, El Palmar, Málaga, Pamplona, Reus, Valencia
2022-03-11
Active, closed
Eli Lilly and Company
Phase 3
874
Barcelona, Cáceres, Lleida, Madrid, San Cristóbal de La Laguna, Valencia, Granada, Seville
2021-10-04
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Córdoba, Esplugues de Llobregat, Sabadell, Valencia
2021-05-26
Active, closed
Eli Lilly and Company
Phase 3
101
Esplugues de Llobregat, Madrid, Málaga, Seville, Valencia
2021-04-13
Active, closed
Eli Lilly and Company
Phase 3
312
Barcelona, Seville, Valencia, Valladolid
2020-11-25
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
DrugsLY3410738·Azacitidine·Venetoclax
Eli Lilly and Company
Phase 1
260
Barcelona, Madrid, Valencia
2020-11-19
Active, closed
Eli Lilly and Company
Phase 3
58
Esplugues de Llobregat, Madrid, Seville, Valencia
2020-02-12
Recruiting
Eli Lilly and Company
Phase 2
105
Barcelona, Esplugues de Llobregat, Madrid, San Cristóbal de La Laguna, Seville, Valencia
2020-01-22
Active, closed
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
DrugsImlunestrant·Alpelisib·Everolimus·Abemaciclib
Eli Lilly and Company
Phase 1
379
Barcelona, Madrid, Valencia
2019-12-10
Active, closed
Eli Lilly and Company
Phase 3
30
Esplugues de Llobregat, Madrid, Valencia
2019-10-16
Recruiting
Eli Lilly and Company
Phase 3
190
Esplugues de Llobregat, Madrid, Seville, Valencia
2019-04-05
Active, closed
Eli Lilly and Company
Phase 3
533
Barcelona, Seville, Valencia, Valladolid
2018-03-14
Active, closed
Eli Lilly and Company
Phase 1
223
Barcelona, Madrid, Valencia
2016-11-21
Active, closed
Eli Lilly and Company
Phase 2
234
Barcelona, Madrid, Valencia
2016-09-14
Active, closed
Eli Lilly and Company
Phase 3
545
Barcelona, Hospitalet, Palma, Pozuelo de Alarcón, Madrid, Pamplona, Seville, Valencia
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
493
Badajoz, Barcelona, Donostia / San Sebastian, Lleida, Madrid, Valencia
2014-11-06
Active, closed
Eli Lilly and Company
Phase 3
453
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Valencia
2014-10-03
Active, closed
Eli Lilly and Company
Phase 3
669
Elche, Barcelona, Lleida, Madrid, Murcia, Valencia
2014-07-22
Rows per page Showing 1–34 of 34
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/valencia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 34 of those studies with a site in Valencia that also match the filters currently applied.

How many clinical trials are recruiting in Valencia?

15 of the 34 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Valencia), 34 studies
PhaseStudiesRecruitingShare
Phase 322964.7%
Phase 18523.5%
Phase 24111.8%

Most active sponsors

Lead sponsors with the most studies (Valencia)
Lead sponsorStudiesRecruiting
Eli Lilly and Company3415
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.